文献速递瓣膜外科

无缝合Perceval瓣膜主动脉瓣置换术后早期传导障碍

Early Conduction Disorders After Aortic Valve Replacement With the Sutureless Perceval Prosthesis.
PubMed 文献 · Ann Thorac Surg · 2021-09-16

本研究纳入908例使用Perceval S瓣膜行主动脉瓣置换术的患者,分析术后传导障碍及起搏器植入率。在801例可评估患者中,完全性房室传导阻滞需起搏器植入的发生率为9.5%,左束支传导阻滞从7.4%增至23.7%。术前右束支传导阻滞、术中瓣膜重新定位、超大号瓣膜及学习曲线期是起搏器植入的独立预测因素。

要点

  • Perceval S瓣膜术后起搏器植入率为9.5%,左束支传导阻滞显著增加。
  • 术前右束支传导阻滞、术中重新定位、超大号瓣膜是起搏器植入预测因素。
  • 需重新评估瓣环尺寸选择策略以减少传导并发症。

核心结论

  • 在高龄高危人群中,Perceval S瓣膜行主动脉瓣置换术手术死亡率低,但起搏器植入率增加。

主要发现

  • 平均年龄79.7±5.2岁,女性476例(59.4%)。
  • 中位logistic EuroSCORE(2011版)为4.1%(IQR 2.6%-6.0%)。
  • 总体30天死亡率为3.9%,单纯主动脉瓣置换为2.8%。
  • 左束支传导阻滞从7.4%增至23.7%(P < .001),完全性房室传导阻滞需起搏器植入发生率为9.5%。

关键数值与推荐

  • 多变量分析显示学习曲线期(OR 1.91,95% CL 1.16-3.13,P = .011)、术前右束支传导阻滞(OR 2.77,95% CL 1.40-5.48,P = .003)、术中瓣膜重新定位(OR 6.70,95% CL 1.89-24.40,P = .003)和超大号瓣膜(OR 6.81,95% CL 1.55-29.96,P = .011)是起搏器植入的显著预测因素。

临床怎么用

  • 术前评估右束支传导阻滞,术中谨慎选择瓣膜尺寸并避免不必要的重新定位,以降低起搏器植入风险。

局限性

  • 回顾性研究设计,可能存在选择偏倚;未报告其他可能影响传导的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study was conducted to determine the incidence of postoperative conduction disorders and need for pacemaker (PM) implantation after aortic valve replacement (AVR) with the Perceval prosthesis (Livanova, Saluggia, Italy). METHODS: From January 2007 to December 2017, 908 patients underwent AVR with Perceval S in 5 participating centers. Study end points focused on electrocardiographic changes after AVR and the incidence of new PM implantation in 801 patients after exclusion of patients with previous PM (n = 48) or patients undergoing tricuspid (n = 28) and/or atrial fibrillation ablation (n = 31) surgery. Logistic regression analysis was performed to determine risk factors for PM need. RESULTS: Mean age was 79.7 ± 5.2 years, and 476 (59.4%) were women. Median logistic European System for Cardiac Operative Risk Evaluation (2011 revision) score was 4.1% (interquartile range, 2.6%-6.0%). Isolated AVR was performed in 441 patients (55.1%). Associated procedures were coronary artery bypass grafting in 309 (38.6%) and mitral valve surgery in 51 (6.4%). Overall 30-day mortality was 3.9% and was 2.8% for isolated AVR. Electrocardiographic changes included a significant increase of left bundle branch block from 7.4% to 23.7% (P < .001) and development of complete atrioventricular block requiring PM implantation in 9.5%. Multivariable analysis revealed independent of a learning period (odds ratio [OR], 1.91; 95% confidence limits (CL), 1.16-3.13; P = .011), preexisting right-bundle branch block (OR, 2.77; 95% CL, 1.40-5.48; P = .003), intraoperative prosthesis repositioning (OR, 6.70; 95% CL, 1.89-24.40; P = .003), and size extra large (OR, 6.81; 95% CL, 1.55-29.96; P = .011) as significant predictors of PM implantation. CONCLUSIONS: In a challenging elderly population, use of the Perceval S for AVR provides low operative mortality but at the risk of an increased PM implantation rate. Besides preexisting right bundle branch block, the significant effect of size extra large, an increased valve size/body surface area ratio, and need for intraoperative repositioning on PM rate are underscoring the reappraisal of the annular sizing policy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Verlinden J, Bové T, de Kerchove L, et al. Early Conduction Disorders After Aortic Valve Replacement With the Sutureless Perceval Prosthesis. Ann Thorac Surg. 2021. PMID: 34536377. doi:10.1016/j.athoracsur.2021.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。